Skandinaviska Enskilda Banken Ab (Publ) Catalyst Pharmaceuticals, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.6 Billion
- Q4 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 731,900 shares of CPRX stock, worth $17.7 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
731,900
Previous 419,900
74.3%
Holding current value
$17.7 Million
Previous $8.35 Million
82.99%
% of portfolio
0.07%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding CPRX
# of Institutions
348Shares Held
98.5MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$453 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$204 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$140 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$75.9 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$73 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.49B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...